Humana Inc.'s (NYSE:HUM) P/E Is On The Mark
The U.S. Uninsured Rate Hits 8%, a Post-pandemic High
CarePlus Launches User-friendly Community Navigator to Help Expand Access to Essential Resources in Florida
Medical costs soar and drag down profits. CVS Health (CVS.US) once again lowered guidance and launched a cost-cutting plan.
CVS Health (CVS.US) announced its second-quarter results.
Humana Foundation Announces 2024 Scholarship Awards
Analysts' Top Healthcare Picks: Laboratory (LH), Humana (HUM)
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Evolus (EOLS) and Humana (HUM)
Richard Pzena's Strategic Moves in Q2 2024: A Closer Look at Humana Inc's Significant Portfolio ...
Express News | Deutsche Bank Maintains Hold on Humana, Raises Price Target to $349
Peering Into Humana's Recent Short Interest
TD Cowen Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $402
Express News | Humana : TD Cowen Cuts Target Price to $402 From $407
TD Cowen Cuts Humana's Price Target to $402 From $407
Express News | Humana : Deutsche Bank Raises Target Price to $349 From $341
Analyst Expectations For Humana's Future
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $364
Jefferies Adjusts Price Target on Humana to $419 From $365
Jefferies Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $419
Humana's Balanced Market Outlook and Cost Control Recovery Justify Buy Rating
Humana Is Maintained at Outperform by Oppenheimer